OraQ Launches AI Driven Support Tool For Dentists in U.S.; Joins Increasingly Crowded Field of Solution Providers
OraQ has officially launched its commercial operations in North America, introducing a new clinical decision support system powered by artificial intelligence (AI) and machine learning. The software platform seeks to aid dentists by providing them with valuable insights and enhancing patient care precision. OraQ’s platform has demonstrated the potential to boost treatment acceptance rates by up to 30%.
Unlike many AI tools available today, OraQ’s platform is not limited to imaging alone. Dr. Mike Parchewsky, co-founder of OraQ, described the platform as a comprehensive treatment planning technology that offers a holistic view of the patient’s profile, revealing treatment opportunities that might otherwise go unnoticed. It also includes an interactive patient portal which can lead to improved patient-clinician interactions by fostering trust and transparency. OraQ™ is approved for use by The FDA and Health Canada. Studies have shown that using the technology can lead to 70% average case acceptance versus the 30-40% industry standard which can add $1,400 per day added revenue potential per dentist.
OraQ will join an increasingly crowded field of dental AI solutions including companies such as Videa Health, Overjet, Pearl, Denti.AI, and Orca Dental AI. These tools have demonstrated the ability to increase dental diagnostic accuracy and foster better patient interaction and compliance. For example, an FDA clinical investigation examining the VideaHealth algorithm, found the incorporation of AI led to 100% of the participating clinicians experienced improved disease detection capabilities when supported by AI, and a 15% decrease in misdiagnoses and a notable 31% enhancement in the detection of cavities in patients.